Growth Metrics

Bruker (BRKR) Receivables - Other (2018 - 2025)

Bruker (BRKR) has disclosed Receivables - Other for 8 consecutive years, with $113.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 20.73% year-over-year to $113.0 million, compared with a TTM value of $113.0 million through Dec 2025, up 20.73%, and an annual FY2025 reading of $113.0 million, up 20.73% over the prior year.
  • Receivables - Other was $113.0 million for Q4 2025 at Bruker, down from $118.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $127.1 million in Q2 2025 and bottomed at $46.1 million in Q4 2021.
  • Average Receivables - Other over 5 years is $79.7 million, with a median of $79.1 million recorded in 2023.
  • The sharpest move saw Receivables - Other fell 4.92% in 2022, then skyrocketed 49.75% in 2023.
  • Year by year, Receivables - Other stood at $46.1 million in 2021, then skyrocketed by 31.89% to $60.8 million in 2022, then skyrocketed by 35.86% to $82.6 million in 2023, then increased by 13.32% to $93.6 million in 2024, then grew by 20.73% to $113.0 million in 2025.
  • Business Quant data shows Receivables - Other for BRKR at $113.0 million in Q4 2025, $118.6 million in Q3 2025, and $127.1 million in Q2 2025.